Prismmulti-framework research
Prism

See every stock through 15+ investor lenses. Research, decide, document — without leaving the page.

For research and education only — not investment advice.

Research
  • Browse
  • Screener
  • Markets
  • Superinvestors
  • Insider tracker
Tools
  • Backtest
  • Calculators
  • Compare
  • Copilot
Workspace
  • Portfolio
  • Watchlist
  • Alerts
  • Weekly digest
  • Learn
© 2026 Prism Finance. All data illustrative.GlossaryContact
  • Browse
  • Screener
  • Disagree
  • Portfolio
PG logo

PG

The Procter & Gamble Company
Consumer DefensiveHousehold & Personal ProductsIncome
$145.54 · 15min delay
β 0.40

A high-quality mega-cap income stock trading at a premium valuation. Frameworks sharply disagree on it.

Download report

52-wk low $137.6252-wk high $170.99

Mkt Cap

$338.90B

P/E

—

PEG

4.11

P/B

6.31

Dividend

2.97%

ROE

31.1%

About the business

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands. In addition, the company offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brands; and gastrointestinal, pain relief, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. Further, it provides fabric enhancers, and laundry additives and detergents under the Ariel, Downy, Gain, and Tide brands; and air and dish care, P&G professional, and surface care under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. Additionally, the company offers baby wipes, and taped diapers and pants under the Luvs and Pampers brands; adult incontinence and menstrual care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. It sells its products through mass merchandisers, social and e-commerce channels, grocery and specialty beauty stores, membership club stores, drug and department stores, distributors, wholesalers, airport duty-free and high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Who would buy PG?

Consensus 27/100 · Polarized · Investors strongly disagree — this is where Prism is most useful.

3 5 7

Endorses

· 3 frameworks
  • Joel Greenblatt· Magic Formula100/100

    ROE > 20% 31.1% clears "> 20.0%".

  • AQR / Asness· Quality Factor100/100

    ROE > 20% 31.1% clears "> 20.0%".

  • Dividend Growth School· Dividend Income88/100

    Dividend Yield > 2% 3.0% clears "> 2.0%".

Insider activity · Negative

Insider selling outweighs buying

Strength 70/100

7 insiders sold $55.5M on a discretionary basis. Discretionary selling carries more signal than planned disposals, but insiders sell for many non-thesis reasons (taxes, diversification, life events) — do not over-read it. Over the 6M window, insiders are net sellers by 11,977 shares.

In Prism's context

Insider selling is worth flagging but insiders sell for many non-thesis reasons. Read alongside the framework verdict (Fails criteria).

InsiderRoleTypeDateSharesAvg priceValueOwn
PORTMAN ROBERT JONESDirectorAward / grantMar 10, 2026193$0.00$0Direct
PORTMAN ROBERT JONESDirectorAward / grantMar 10, 202649$0.00$0Direct
MCEVOY ASHLEYDirectorAward / grantMar 10, 2026161$0.00$0Direct
MCCARTHY CHRISTINE M.DirectorAward / grantMar 10, 2026209$0.00$0Direct
JIMENEZ JOSEPH JRDirectorAward / grantMar 10, 2026273$0.00$0Direct
ARNOLD CRAIGDirectorAward / grantMar 10, 2026161$0.00$0Direct
KEMPCZINSKI CHRISTOPHER JDirectorAward / grantMar 10, 2026201$0.00$0Direct
FRANCISCO MA. FATIMAOfficerOpen-market sellFeb 27, 20265,549$165.29$917KDirect
WHALEY SUSAN STREETOfficerOpen-market sellFeb 19, 20261,809$159.45$288KDirect
AGUILAR MOSES VICTOR JAVIEROfficerOpen-market sellFeb 13, 202615,169$162.28$2.46MDirect
AGUILAR MOSES VICTOR JAVIEROfficerOption exerciseFeb 13, 202615,169$91.07$1.38MDirect
COOMBE GARY AOfficerOpen-market sellFeb 12, 202636,093$162.33$5.86MDirect
COOMBE GARY AOfficerOption exerciseFeb 12, 202636,093$78.52$2.83MDirect
MOELLER JON ROfficer and DirectorOpen-market sellFeb 12, 2026173,268$162.29$28.12MDirect
MOELLER JON ROfficer and DirectorOption exerciseFeb 12, 2026173,268$113.23$19.62MDirect
PURUSHOTHAMAN BALAJIOfficerOpen-market sellFeb 11, 202612,827$160.31$2.06MDirect
PURUSHOTHAMAN BALAJIOfficerOption exerciseFeb 11, 202612,827$91.07$1.17MDirect
FRANCISCO MA. FATIMAOfficerOpen-market sellFeb 4, 20268,000$158.00$1.26MDirect
PRITCHARD MARC SOfficerOpen-market sellJan 23, 202695,903$151.15$14.50MDirect
PRITCHARD MARC SOfficerOption exerciseJan 23, 202695,903$80.29$7.70MDirect
PORTMAN ROBERT JONESDirectorAward / grantDec 9, 202554$0.00$0Direct
MCEVOY ASHLEYDirectorAward / grantDec 9, 2025215$0.00$0Direct
MCCARTHY CHRISTINE M.DirectorAward / grantDec 9, 2025269$0.00$0Direct
JIMENEZ JOSEPH JRDirectorAward / grantDec 9, 2025341$0.00$0Direct
ARNOLD CRAIGDirectorAward / grantDec 9, 2025215$0.00$0Direct
KEMPCZINSKI CHRISTOPHER JDirectorAward / grantDec 9, 2025260$0.00$0Direct
RAMAN SUNDAR G.OfficerOption exerciseDec 3, 202559$145.41$9KDirect
DAVIS JENNIFER LOfficerOption exerciseDec 3, 202560$145.38$9KDirect
WHALEY SUSAN STREETOfficerOption exerciseDec 3, 202554$145.39$8KDirect
PURUSHOTHAMAN BALAJIOfficerOption exerciseDec 3, 202538$145.37$6KDirect
BHARUCHA FREDDY POfficerOption exerciseDec 3, 202545$145.38$7KDirect
JEJURIKAR SHAILESHChief Operating OfficerOption exerciseDec 3, 202551$145.39$7KDirect
FRANCISCO MA. FATIMAOfficerOption exerciseDec 3, 202573$145.40$11KDirect
AGUILAR MOSES VICTOR JAVIEROfficerOption exerciseDec 3, 202555$145.40$8KDirect
SCHULTEN ANDREChief Financial OfficerOption exerciseDec 3, 202588$145.39$13KDirect
PRITCHARD MARC SOfficerOption exerciseDec 3, 202594$145.39$14KDirect
MOELLER JON RChief Executive OfficerOption exerciseDec 3, 2025159$144.48$23KDirect

Insider activity from Yahoo Finance (quoteSummary: insiderTransactions + netSharePurchaseActivity). Cached 6 hours. · Insiders hold 0.1% of shares outstanding.

Net 6M: -11,977 sh

Price history

—
Loading…

Drag across the chart to select a custom period — all analysis below refocuses to that window.

What this means: Price near 52-week lows confirms what most frameworks are already flagging: the market is discounting deteriorating fundamentals.

Premium view

AI summaries

Members get a plain-English 'what matters now' brief plus an explanation of why the price is moving, grounded in Prism's framework scores.

Premium view

Full framework decision report

See how Lynch, Buffett, Graham, Greenblatt, Fisher and more each score this stock — with every rule, threshold, and reason exposed.

Premium view

Peer comparison + AI read-through

See how this stock stacks up against its closest peers on valuation, growth, and returns — with a written peer summary.

What would PG do to your portfolio?

Add The Procter & Gamble Company at a hypothetical weight and Prism recalculates your whole book:

Risk metrics

Sharpe, Sortino, volatility, max drawdown, beta — before and after.

Sector concentration

How much this shifts your top sector weight and overall diversification.

Archetype tilt

Whether this leans your book more toward Quality, Value, Growth, Deep Value, Income, or Momentum.

PG is currently tagged:IncomeFails criteria (27/100)

Portfolio analytics are part of the member experience.

Sign in to run this simulation
Probabilistic recommendation· rec-v1.0.0-2026-04

The Procter & Gamble Company · PG

PG: 48% estimated probability of outperforming over the next 12M window. 1 of 6 signal families negative (medium confidence). Strongest support: ROE 31%. Main risk to monitor: 23% above fair value.

Outperform prob.
48%
vs S&P 500 · 12M
medium confidence
Expected return
-4.3% → +19.7%
mid +7.7% / yr
Downside (p20)
-6.8%
stress -13.6%
Data quality
95/100
Excellent

Probabilistic research output, not financial advice. Prism recommendations are based on available data, historical relationships, and model assumptions. They do not guarantee future returns. Conduct independent due diligence before any investment decision.

Backtested and similar-setup statistics may be affected by survivorship bias, look-ahead bias, overfitting, transaction costs, liquidity constraints, and data limitations. Probability estimates are anchored heuristics — not validated forecasts — until the walk-forward backtest pipeline is in place.

Prism Score

Composite 54/100. Strongest contribution from quality; weakest from ownership. Risk patterns shaved 2 points off the composite.

Composite
54
/ 100
Mixed
Deep valueval.
48/ 100

P/B 6.31× · FCF yield 3.8%

Margin of safetyval.
37/ 100

23% above fair value

Bull · base · bear scenarios

Three plausible paths over a 5-year horizon.

Indicative only. Probabilities are model-implied weights for stress-testing — not forecasts.

Bull
~25%
$153.82
+1.1% / yr (5y)

Operating leverage kicks in or a new product line scales — margins inflect higher, growth steps up by 200–400 bps, and the multiple re-rates as the durability becomes obvious to a wider audience.

Drivers
  • • Margin expands by 200–400 bps from 23%
  • • Top-line accelerates 300–500 bps above current
  • • Multiple re-rates one full turn higher
Base
~55%
$118.32
-4.1% / yr (5y)

Business continues to compound at recent rates — 23% operating margin holds, 7% top-line growth persists, capital allocation stays disciplined. Multiple stays roughly where it is.

Global value comparison

The Procter & Gamble Company vs sector medians — GCC, MENA, and Global ex-US.

Sector: Consumer Defensive. MENA-aware investors can sanity-check whether the US name is offering value relative to regional peers.

MetricPGGCC medianMENA medianGlobal ex-US
P/E (TTM)—18.0×15.0×17.0×
P/B6.31×3.50×2.80×3.20×
Dividend yield2.97%3.20%2.80%2.60%
ROE31.1%
Earnings reaction explainer

PG blew past estimates by 11.6%.

Big beat· +11.6%

Reported EPS $1.59 vs $1.42 expected — well outside the normal beat-and-raise band. The market typically rewards a print this size only if it is read as durable, not one-off. Trailing operating margin: 23.0%.

  • Growth investorsPositive

    Confirms operating leverage — 6% trailing EPS growth + a beat of this size is the pattern that drives multi-year re-rates.

  • Quality investorsPositive

    If ROE (31%) and operating margin (23%) are stable or rising, the beat is consistent with compounding rather than one-off.

  • Value investorsNeutral

    A blow-out can pull future quarters forward — value investors will look for sustained margin, not a single-quarter spike.

News & events

Next earnings

Wed, Jul 29 · consensus EPS $1.42 · last actual $1.59

  • Men's Skincare Products Market Report 2026: L'Oreal, P&G, Unilever, and Beiersdorf Dominate Through Strong Brand Equity, Extensive Distribution Channels, and Continuous Innovations - Forecast to 2031

    GlobeNewswire · just now

  • Is Procter & Gamble's Baby Care Slump Dragging Overall Growth?

    Zacks · just now

  • These Are the 10 Largest Consumer Staples Stocks in May -- How to Pick the Top Investments

Key Metrics at a Glance

P/E Ratio (TTM)

N/A

PEG Ratio

4.11

P/B Ratio

6.31

EPS Growth

5.8%

Revenue Growth

7.4%

Debt / Equity

0.68

Net Cash / Share

$-10.62

Return on Equity

31.1%

Gross Margin

51.0%

Operating Margin

23.0%

FCF / Share

$5.47

Current Ratio

0.73

Rejects

· 3 frameworks
  • Peter Lynch· Lynch GARP0/100

    PEG < 1 (growth at a discount) is 4.11× — fails "< 1.00×".

  • Walter Schloss· Schloss Deep Value0/100

    P/B < 1.0 (below book) is 6.31× — fails "< 1.00×".

  • Seth Klarman· Klarman Margin of Safety0/100

    FCF Yield > 7% is 3.8% — fails "> 7.0%".

See the full rule-by-rule drill-down below
Prism Score
54/100
Low agreement
Signal families · 1 of 6 signal families negative
Agreement: Low
  • Valuationnegative

    Trades meaningfully above the fair-value range — limited margin of safety.

    23% above fair value
    25
    /100
  • Qualitypositive

    Returns and margins are healthy and consistent.

    ROE 31%Op margin 23%Gross 51%
    81
    /100
  • Balance sheetnegative

    Leverage is high relative to coverage — balance-sheet risk on the table.

    CR 0.73 (tight)
    40
    /100
  • Momentumneutral

    Price trend is unremarkable — neither tailwind nor headwind.

    46
    /100
  • Behaviouralnegative

    Informed money is leaning the other way — net selling or thin interest.

    Net insider selling ($55.6M)
    38
    /100
  • Catalysts & eventsneutral

    Mixed catalyst picture.

    Big EPS beat (+12%)1 medium-severity flag
    56
    /100
Positive drivers
  • • ROE 31%
  • • Op margin 23%
  • • Gross 51%
Key risks
  • • 23% above fair value
  • • CR 0.73 (tight)
  • • Net insider selling ($55.6M)
  • • Possible quality trap (paying up)
Suggested diligence questions
  • 1. Multiple compression
Similar historical setups[MOCK DATA]

Among 98 historical setups with similar Prism Score and signal-agreement profiles, 49% beat the benchmark over the next 12 months, with average excess return of -0.2% / yr.

Probabilistic research output — not financial advice.
View full thesis
Quality20%
90/ 100

ROE 31% · Op margin 23%

Balance sheet15%
64/ 100

D/E 0.68 · CR 0.73

Insider convictionown.
5/ 100

Net selling — 9 insiders

Superinvestorown.
35/ 100

No tracked superinvestor holds it

Shareholder yield10%
70/ 100

2.97% yield + buyback runway

Momentum5%
39/ 100

24% through 52w range

Growth5%
56/ 100

EPS 6% · Rev 7%

Risk deduction: 1 pattern flagged · possible quality trap (paying up). 2 points removed from composite.

Designed to surface potentially attractive characteristics — descriptive, not prescriptive. For research and educational purposes only.

Customise weights
Drivers
  • • Revenue growth holds near 7%
  • • Operating margin stays around 23%
  • • Capital returns continue at current cadence
Bear
~20%
$88.74
-9.4% / yr (5y)

A growth-rate scare or a quarter of margin compression resets the multiple. The business is still fine, but the price was assuming a level of compounding that takes 12–24 months to re-prove.

Drivers
  • • Growth decelerates by ~300 bps for two consecutive quarters
  • • Multiple compresses as estimates roll back
  • • Sentiment de-rates the name to a deeper-value multiple
Indicative weights
18.0%
16.0%
14.0%

Editorial dataset · as of 2024-12-31. Sector medians are hand-maintained from public Tadawul / ADX / DFM / QSE / EGX disclosures and indicative Global ex-US references. Live licensed data is on the roadmap. For research and educational purposes only.

What to watch on the next print
  • • Whether margin expansion sustains into next quarter
  • • Forward guidance update — beats without raises tend to fade

Motley Fool · just now

  • Beauty’s Highest-paid CEOs

    WWD · just now

  • Too Many Tech Stocks Lurking in Your Portfolio? These 3 Investments Offer More Balance.

    Motley Fool · just now

  • 1 Oversold Stock Ready to Bounce Back and 2 We Turn Down

    StockStory · just now

  • Institutional Own.

    70.4%

    Insider Own.

    0.1%

    Dividend Yield

    2.97%

    Book Value / Share

    $23.08